Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor Model

CardioVascular and Interventional Radiology

Volumn 34, Issue 5, 2011, Pages 1021-1030

  Gupta, Sanjay ^a   Wright, Kenneth C ^a   Ensor, Joe ^a   Van Pelt, Carolyn S ^a   Dixon, Katherine A ^a   Kundra, Vikas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Drug eluting microspheres; Hepatic artery embolization; Pharmacokinetics

Indexed keywords

DOXORUBICIN; EMBOSPHERE; IODINATED POPPYSEED OIL; MICROSPHERE; SUPERABSORBENT POLYER MICROSPHERE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOEMBOLIZATION; CONTROLLED STUDY; DRUG TUMOR LEVEL; FLUORESCENCE MICROSCOPY; HEPATIC ARTERY; LIVER TUMOR; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ACRYLIC RESINS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; DRUG CARRIERS; ETHIODIZED OIL; GELATIN; HEPATIC ARTERY; LIVER FUNCTION TESTS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICROSCOPY, FLUORESCENCE; MICROSPHERES; POLYMERS; RABBITS;

EID: 80555150829     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0154-6     Document Type: Article

References (43)

1. Dodd GD 3rd, Soulen MC, Kane RA et al (2000) Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 20:9-27
2. Liem MS, Poon RT, Lo CM et al (2005) Outcome oftransarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation. World J Gastro-enterol 11:4465-4471 (Pubitemid 41150384)
3. Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164-1171 (Pubitemid 34454013)
4. Maataoui A, Qian J, Vossoughi D et al (2005) Transarterial chemoembolization alone and in combination with other thera-pies: a comparative study in an animal HCC model. Eur Radiol 15:127-133 (Pubitemid 40109781)
5. Martin M, Tarara D, Wu YM et al (1996) Intrahepatic arterial chemoembolization for hepatocellular carcinoma and metastatic neuroendocrine tumors in the era of liver transplantation. Am Surg 62:724-732 (Pubitemid 126751373)
6. Llovet JM, Bruix J (2003) Systematic review ofrandomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 37:429-442 (Pubitemid 36152543)
7. Llovet JM, Real MI, Montana X et al (2002) Arterial embolisa-tion or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a random-ised controlled trial. Lancet 359:1734-1739 (Pubitemid 34607087)
8. Dhanasekaran R, Kooby DA, Staley CA et al (2010) Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC). J Surg Oncol 101:476-480
9. Eyol E, Boleij A, Taylor RR et al (2008) Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin. Clin Exp Metastasis 25:273-282
10. Hong K, Khwaja A, Liapi E et al (2006) New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12:2563-2567
11. Kettenbach J, Stadler A, Katzler IV et al (2008) Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol 31:468-476
12. Lammer J, Malagari K, Vogl T et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41-52
13. Lewis AL, Gonzalez MV, Lloyd AW et al (2006) DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17:335-342 (Pubitemid 44341453)
14. Lewis AL, Taylor RR, Hall B et al (2006) Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 17:1335-1343 (Pubitemid 44259017)
15. Taylor RR, Tang Y, Gonzalez MV et al (2007) Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 30:7-14 (Pubitemid 44908921)
16. Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46:474-481 (Pubitemid 46201723)
17. Egorin MJ (1998) Overview of recent topics in clinical phar-macology of anticancer agents. Cancer Chemother Pharmacol 42(Suppl):S22-S30
18. Emerich DF, Snodgrass P, Lafreniere D et al (2002) Sustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusions. Pharm Res 19:1052-1060 (Pubitemid 34804250)
19. Shapiro GI, Harper JW (1999) Anticancer drug targets: cell cycle and checkpoint control. J Clin Invest 104:1645-1653 (Pubitemid 30053178)
20. Khankan AA, Osuga K, Hori S et al (2004) Embolic effects of superabsorbent polymer microspheres in rabbit renal model: comparison with tris-acryl gelatin microspheres and polyvinyl alcohol. Radiat Med 22:384-390 (Pubitemid 40144015)
21. Bilbao JI, de Luis E, Garcia de Jalon JA et al (2008) Comparative study of four different spherical embolic particles in an animal model: a morphologic and histologic evaluation. J Vasc Interv Radiol 19:1625-1638
22. De Luis E, Bilbao JI, de Ciercoles JA et al (2008) In vivo eval-uation of a new embolic spherical particle (Hepa Sphere) in a kidney animal model. Cardiovasc Intervent Radiol 31:367-376
23. Jiaqi Y, Hori S, Minamitani K et al (1996) A new embolic material: super absorbent polymer (SAP) microsphere and its embolic effects. Nippon Igaku Hoshasen Gakkai Zasshi 56:19-24 (Pubitemid 126462583)
24. Osuga K, Hori S, Hiraishi K et al (2008) Bland embolization of hepatocellular carcinoma using superabsorbent polymer micro-spheres. Cardiovasc Intervent Radiol 31:1108-1116
25. Jordan O, Denys A, De Baere T et al (2010) Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan. J Vasc Interv Radiol 21(7):1084-1090
26. Lee KH, Liapi EA, Cornell C et al (2010) Doxorubicin-loaded Quadra Sphere microspheres: plasma pharmacokinetics and intra-tumoral drug concentration in an animal model of liver cancer. Cardiovasc Intervent Radiol 33(3):576-582
27. Ko YH, Pedersen PL, Geschwind JF (2001) Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett 173:83-91 (Pubitemid 32907513)
28. Taylor S, Folkman J (1982) Protamine is an inhibitor of angio-genesis. Nature 297:307-312
29. Geschwind JF, Ko YH, Torbenson MS et al (2002) Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res 62:3909-3913 (Pubitemid 34791050)
30. Furuta T, Kanematsu T, Kakizoe S et al (1983) Selective effect of doxorubicin suspended in lipiodol on VX2 carcinoma in rabbits. J Surg Oncol 39:229-234 (Pubitemid 19007284)
31. Iwai K, Maeda H, Konno T et al (1987) Tumor targeting by arterial administration of lipids: rabbit model with VX2 carci-noma in the liver. Anticancer Res 7:321-327 (Pubitemid 17151906)
32. Nagamitsu A, Konno T, Oda T et al (1993) Targeted cancer chemotherapy for VX2 tumour implanted in the colon with lipiodol as a carrier. Eur J Cancer 34:1764-1769 (Pubitemid 28474233)
33. Kan Z (1994) Iodized oil injected in the hepatic artery will enter the portal vein. J Vasc Interv Radiol 5:525-526
34. Kan Z (1996) Dynamic study of iodized oil in the liver and blood supply to hepatic tumors. An experimental investigation in sev-eral animal species. Acta Radiol Suppl 408:1-25
35. Kan Z, Sato M, Ivancev K et al (1993) Distribution and effect of iodized poppyseed oil in the liver after hepatic artery emboliza-tion: experimental study in several animal species. Radiology 186:861-866 (Pubitemid 23073535)
36. Kan Z, Wright K, Wallace S (1997) Ethiodized oil emulsions in hepatic microcirculation: in vivo microscopy in animal models. Acad Radiol 4(4):275-282 (Pubitemid 127469851)
37. Nakamura H, Hashimoto T, Oi H et al (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170:783-786 (Pubitemid 19062602)
38. Olivi A, Brem H (1994) Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas. Recent Results Cancer Res 135:149-154
39. Osuga K, Hori S, Kitayoshi H et al (2002) Embolization of high flow arteriovenous malformations: experience with use of superabsorbent polymer microspheres. J Vasc Interv Radiol 13: 1125-1133 (Pubitemid 35332898)
40. Osuga K, Khankan AA, Hori S et al (2002) Transarterial embo-lization for large hepatocellular carcinoma with use of superab-sorbent polymer microspheres: initial experience. J Vasc Interv Radiol 13:929-934
41. Stampfl S, Stampfl U, Rehnitz C et al (2007) Experimental evaluation of early and long-term effects of microparticle embolization in two different mini-pig models. Part II: liver. Cardiovasc Intervent Radiol 30:462-468 (Pubitemid 46599088)
42. Siskin GP, Dowling K, Virmani R et al (2003) Pathologic eval-uation of a spherical polyvinyl alcohol embolic agent in a porcine renal model. J Vasc Interv Radiol 14:89-98 (Pubitemid 36134079)
43. Derdeyn CP, Graves VB, Salamat MS et al (1997) Collagen-coated acrylic microspheres for embolotherapy: in vivo and in vitro characteristics. AJNR Am J Neuroradiol 18:647-653 (Pubitemid 27175959)